Peter L Nara
Peter L Nara
Keystone Bio Inc.
Verified email at
Cited by
Cited by
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
DR Burton, J Pyati, R Koduri, SJ Sharp, GB Thornton, PWHI Parren, ...
Science 266 (5187), 1024-1027, 1994
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide …
MR Boyd, KR Gustafson, JB McMahon, RH Shoemaker, BR O'Keefe, ...
Antimicrobial agents and chemotherapy 41 (7), 1521-1530, 1997
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
M Girard, MP Kieny, A Pinter, F Barre-Sinoussi, P Nara, H Kolbe, ...
Proceedings of the National Academy of Sciences 88 (2), 542-546, 1991
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.
CF Barbas 3rd, D Hu, N Dunlop, L Sawyer, D Cababa, RM Hendry, ...
Proceedings of the National Academy of Sciences 91 (9), 3809-3813, 1994
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
CF Barbas 3rd, E Björling, F Chiodi, N Dunlop, D Cababa, TM Jones, ...
Proceedings of the National Academy of Sciences 89 (19), 9339-9343, 1992
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody
PL Nara, WC Hatch, NM Dunlop, WG Robey, LO Arthur, MA Gonda, ...
AIDS research and human retroviruses 3 (3), 283-302, 1987
MAP 30: a new inhibitor of HIV-1 infection and replication
S Lee-Huang, PL Huang, PL Nara, HC Chen, H Kung, P Huang, ...
FEBS letters 272 (1-2), 12-18, 1990
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees
PL Nara, L Smit, N Dunlop, W Hatch, M Merges, D Waters, J Kelliher, ...
Journal of virology 64 (8), 3779-3791, 1990
HIV requires multiple gp120 molecules for CD4-mediated infection
SP Layne, MJ Merges, M Dembo, JL Spouge, PL Nara
Nature 346 (6281), 277-279, 1990
The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
S Jurriaans, B Van Gemen, GJ Weverling, D Van Strup, P Nara, ...
Virology 204 (1), 223-233, 1994
Neutralization of HIV‐1: a paradox of humoral proportions
PL Nara, RR Garrity, J Goudsmit
The FASEB journal 5 (10), 2437-2455, 1991
A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS
D Zagury, J Bernard, R Cheynier, I Desportes, R Leonard, M Fouchard, ...
Nature 332 (6166), 728-731, 1988
The role of the V3 loop of gp 120 in HIV infection
JP Moore, PL Nara
Aids 5, 21-34, 1991
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees
EA Emini, PL Nara, WA Schleif, JA Lewis, JP Davide, DR Lee, J Kessler, ...
Journal of Virology 64 (8), 3674-3678, 1990
Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.
RR Garrity, G Rimmelzwaan, A Minassian, WP Tsai, G Lin, JJ De Jong, ...
Journal of immunology (Baltimore, Md.: 1950) 159 (1), 279-289, 1997
Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity
JD Lifson, KM Hwang, PL Nara, B Fraser, M Padgett, NM Dunlop, ...
Science 241 (4866), 712-716, 1988
Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections.
JM Ward, TJ O'Leary, GB Baskin, R Benveniste, CA Harris, PL Nara, ...
The American journal of pathology 127 (2), 199, 1987
Quantitative infectivity assay for HIV-1 and-2
PL Nara, PJ Fischinger
Nature 332 (6163), 469-470, 1988
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells
PN Fultz, P Nara, F Barre-Sinoussi, A Chaput, ML Greenberg, ...
Science 256 (5064), 1687-1690, 1992
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 …
JD Ahlers, N Dunlop, DW Alling, PL Nara, JA Berzofsky
Journal of immunology (Baltimore, Md.: 1950) 158 (8), 3947-3958, 1997
The system can't perform the operation now. Try again later.
Articles 1–20